Kimberly Ha of BioPharm Insight Identifies Disruptive Trends and Technologies in Biotechnology

Kimberly Ha notes that many big pharma companies are partnering with academic institutions and that oncology, followed by neurology is one of the hottest areas in acquisitions

Read more »